Union Chemicals and Fertilisers Minister J P Nadda addressed the Rajya Sabha on February 3, 2026, reaffirming the government's dedication to a robust drug pricing policy designed to ensure that essential medicines remain affordable for all citizens. During the Question Hour, he emphasized the critical balance between fostering growth within the pharmaceutical industry and maintaining accessibility to necessary medications for the public.
Minister Nadda outlined several initiatives that the government has implemented to alleviate the financial burden on citizens regarding healthcare costs. One key program is the National Health Mission, which provides free drugs and diagnostic services to the public. Additionally, the Jan Aushadhi Kendras have been established to offer high-quality generic medicines at significantly lower prices, making healthcare more accessible.
- Out-of-pocket healthcare expenditure reduced — has decreased from 62.6% to 39.4% in the last decade.
- Regular updates of DPCO 2013 — ensuring the Drug (Prices Control) Order remains effective in regulating prices.
- Consultations with stakeholders — the National Pharmaceutical Pricing Authority (NPPA) engages with stakeholders to enhance pricing policies.
Nadda noted that the significant decline in out-of-pocket expenses is largely attributed to the government's consistent efforts in price regulation and the expansion of healthcare services. He also stressed that the review of the Drug (Prices Control) Order 2013 is an ongoing process that aims to ensure the legal framework remains effective in enforcing price caps on essential medications.
